MAGZEN® Effect on Recent Anxiety Reaction

Multicentres, observational study, prospective, to evaluate the effect of MAGZEN® in the treatment of recent anxiety reaction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anxiety Disorders Mental Disorders

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Private practice

Marseille, France

About this study

107 patients suffering from recent anxiety reaction will be included in the study. They will be treated by MAGZEN® during 4 weeks and we will study the effect of this treatment on the evolution of their anxiety after the cure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient suffering from recent anxiety reaction
Hamilton-anxiety score ≥ 20 at inclusion
recent anxiety disorders (less than 3 months) not treated by pharmacological or psychological treatment

Exclusion criteria

major depressive syndrome
anxiety disorders more than 3 months
anxiety due to death

Treatment and study plan

Hamilton-anxiety scale (HAM-A)

Other

Evolution of anxiety disorders is evaluated by the Hamilton-anxiety scale (HAM-A)

Primary outcomes

number of "responders patients"

Time frame: 4 weeks

number (%) of "responders patients" with a diminution of the HAM-A score ≥ 50 %

Sponsors and collaborators

Lead sponsor

Laboratoire Dielen

Industry

Registry information

Official study title

MAGZEN® Effect on Recent Anxiety Reaction (STRESS2)

Acronym: STRESS2

Important dates

Study start: 2019
Primary completion: 2021
Study completion: 2021
First posted: Jul 27, 2018
Registry last updated: Aug 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed